Unlikely to cause harm — often a labeling or packaging issue.
Failed Dissolution Specifications
| Brand name | BUPROPION HYDROCHLORIDE |
| Generic name | BUPROPION HYDROCHLORIDE |
| Active ingredient(s) | BUPROPION HYDROCHLORIDE |
| Distributed by / for | Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 |
| NDC | 47335-737-86 |
| Full product label | buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86 |
| Recalling firm | Sun Pharmaceutical Industries, Inc. |
| Distribution | Nationwide |
| Quantity | 16,085 bottles |
| Recall initiated | 2016-06-27 |
| Report date | 2016-07-27 |
| Recall completed | 2018-03-27 |
| Recall number | D-1446-2016 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Cranbury NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗